Daniel Hardy, MD
Neurology · Richmond, VANPI 1932179462
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $332,571 of the $382,170 with a category attached, or 87.0%. 60 manufacturers reported payments, led by EMD Serono, Inc. at 52.5% of the total. 2025 is the largest year on record at $96,853, 2.4 times the $41,162 reported in 2019. Among neurology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,386 payments — averaging $275.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$201K
- Biogen$80K
- AbbVie$49K
- Pfizer$20K
- Biohaven Pharmaceuticals, Inc.$15K
- Biohaven Pharmaceutical Holding Company Ltd.$6K
- plus $13K from 54 others
What the payments were for
- Consulting fees$8,0722%
- Speaking & faculty fees$332,57187%
- Travel & lodging$12,5483%
- Food & beverage$28,5427%
- Education$4370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$382,170 in reported general payments places this provider in the 95th percentile of 474 neurology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AubagioTeriflunomide | 14 | $131,602 |
| VumerityDiroximel Fumarate | 11 | $92,032 |
| Nurtec OdtRimegepant Sulfate | 35 | $44,167 |
| UbrelvyUbrogepant | 31 | $41,746 |
| GlatopaGlatiramer Acetate | 13 | $34,944 |
| Emgality PenGalcanezumab-Gnlm | 37 | $27,963 |
| Aimovig AutoinjectorErenumab-Aooe | 23 | $22,930 |
| QuliptaAtogepant | 11 | $13,383 |
| Teriflunomide | 22 | $9,224 |
| Eletriptan HbrEletriptan Hydrobromide | 26 | $7,898 |
| Sumatriptan Succinate | 114 | $4,839 |
| Memantine Hcl ErMemantine Hcl | 14 | $3,709 |
| Donepezil Hcl | 359 | $3,358 |
| Carbamazepine ErCarbamazepine | 18 | $3,299 |
| Pregabalin | 46 | $3,109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SanofiAubagio | $596 | $131,60214 claims |
| BiogenVumerity | $79,708 | $92,03211 claims |
| AbbVieUbrelvy, Qulipta | $48,610 | $55,12942 claims |
| PfizerNurtec Odt | $19,730 | $44,16735 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 474 neurology providers in Virginia.
Other neurology in Richmond
- Catherine HamRichmond$603K
- Myla GoldmanRichmond$132K
- Alan SchulmanRichmond$104K
- Warren FeltonRichmond$96K
- John WittmanRichmond$61K
- Matthew BoyceRichmond$56K
- Leslie CloudRichmond$46K
- Jonathan BekensteinRichmond$37K
- Jessica LehositRichmond$35K
- Claudia TestaRichmond$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.